Cite
Evaluation of the pharmacokinetics, tissue distribution and excretion studies of YMR-65, a tubulin polymerization inhibitor with potential anticancer activity, in rats using UPLC-MS/MS.
MLA
Fan, Ali, et al. “Evaluation of the Pharmacokinetics, Tissue Distribution and Excretion Studies of YMR-65, a Tubulin Polymerization Inhibitor with Potential Anticancer Activity, in Rats Using UPLC-MS/MS.” Xenobiotica, vol. 48, no. 9, Sept. 2018, pp. 920–26. EBSCOhost, https://doi.org/10.1080/00498254.2017.1380865.
APA
Fan, A., Zhang, Y., Zhang, Q., Wei, J., Lu, X., Ren, G., Zhao, D., Li, N., Zhu, H., & Chen, X. (2018). Evaluation of the pharmacokinetics, tissue distribution and excretion studies of YMR-65, a tubulin polymerization inhibitor with potential anticancer activity, in rats using UPLC-MS/MS. Xenobiotica, 48(9), 920–926. https://doi.org/10.1080/00498254.2017.1380865
Chicago
Fan, Ali, Yaliang Zhang, Qing Zhang, Jiali Wei, Xiaoyu Lu, Guanghui Ren, Di Zhao, Ning Li, Hailiang Zhu, and Xijing Chen. 2018. “Evaluation of the Pharmacokinetics, Tissue Distribution and Excretion Studies of YMR-65, a Tubulin Polymerization Inhibitor with Potential Anticancer Activity, in Rats Using UPLC-MS/MS.” Xenobiotica 48 (9): 920–26. doi:10.1080/00498254.2017.1380865.